Brain Cancer Risk: Family history plays a key role.

A new study suggests that if you a family history of cancerous brain tumors, it may put you at a higher risk of developing the same kind of tumors.

In this study, published in the Sept. 23 issue of Neurology, the researchers examined the medical records and family histories of almost 1,401 people who had either astrocytomas (tumors in the brain or spinal cord) or glioblastomas that is considered a more aggressive kind of astrocytomas. …Click here to read more

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

New hopes for block on cancer

According to American scientists, a big step has been taken to block the chemical that plays a key role in the growth of several cancers.

The scientists have unpicked the structure of an enzyme known as telomerase and it helps to keep cells in an undying state when it is active.

In more than nine out of ten types of tumors, telomerase seems to work.

The study, which conducted by Philadelphia’s Wistar Institute’s researchers, has been published in the journal Nature …Click here to read more

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Run! If you want to defeat aging

The risk of premature death from cancer is less than half in elderly runners than non-runners.

According to the Stanford University Medical Centre team’s report, elderly joggers enjoyed a healthier life with fewer disabilities.

The findings have been published in Archives of Internal Medicine and they stress on the importance of regular exercise for older people. …Click here to read more

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cancer growth may slow down by using high dose vitamin C injection.

Vitamin-CAccording to the US scientists, a high dose vitamin C injection may help to hold the advance of cancers back. The scientists believe that the vitamin may initiate a critical chain reaction in the cancerous cell.

When that injection was given to mice, it halved the size of pancreatic, ovarian and brain tumors. The report has been presented in the journal Proceedings of the National Academy of Sciences.

But the scientists from Cancer Research UK believe that high doses of vitamin C may interfere with cancer treatment as it has been suggested by many studies.

…Click here to read more

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Recurrence of stomach cancer can be prevented by eradicating H. pylori (a common bug) from the stomach, a new study suggests.

Helicobacter pylori that has proved as a cause of stomach ulcers also has link with stomach cancer, a new study suggests.

The researchers investigated the cases of 550 people who had surgery for their stomach cancer. They found that the risk of developing cancer second time decreased twice by using antibiotics that killed Helicobacter pylori.

To find whether killing of the bacterium really stops the development of the cancer, more than 56,000 British people will be under a trial soon. …Click here to read more

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Skin cancer rates are on increase among younger women in the U.S., results of analysis suggest.

skin-cancerpic.jpgAccording to federal health officials reports, though the rates of new skin cancer cases has become steady in younger men, the number of women who are being diagnosed with skin cancer is on increase.

The U.S. government cancer statistics for the period 1973 to 2004 suggest that there has been a 50 % increase in new melanoma cases in younger women since 1980 but there was no increase for younger men during this period.

“It’s quite alarming” stated Mark Purdue who made the analysis for these statistics and it was published in the journal of Investigative Dermatology. “The things we are noticing in young adults at that time could predict a greater number of melanoma cases in older women.” …Click here to read more

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shifting From Open To Robotic Prostatectomy

Institutional impact on number of pelvic lymph nodes retrieved during RALRP while using robotic and open prostatectomy.

Open pelvic lymph node surgery (PLND) remains the best choice in patients with transitional and high-risk prostate cancer undergoing radical retro-pubic prostatectomy (RRP). A group in Rhode Island has adopted robotic-assisted for radical prostatectomy. They wanted to conclude whether robot-assisted laparoscopic PLND yields equivalent numbers of lymph nodes in comparison with open PLND.

After the approval of IRB institute, the databases of open and robotic prostatectomy reviewed at this institution. Patients undergoing RALRP with robotic PLND over a period of one year and patients undergoing open radical prostatectomy with open PLND within the last 5 years were documented. The pathology reports of surgery were keenly examined again to decide the number of lymph nodes obtained from each surgery of PLND. Statistical analysis was performed using Student’s t-test.

…Click here to read more

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Mammogram Assists older Dutch Women

 A new research has been conducted in the laboratories of Holland that the mammogram would help the female in securing their lives. This would also increase the life cycle of the women.
If we look at the cultural life of the Holland people, we would immediately imagine that the women are hard worker and inclined into social spheres than the men. The average life span of the Dutch woman is about 75 years.

The women are fighting with various cancer diseases in Holland. These are the lung cancer, breast cancer, brain tumor, liver cancer and blood cancer etc. Meanwhile the use of mammograms has increased the intensity of the women. Their life activities are the same as before the diagnosis of the cancer diseases. So they are more happy, secured and chilly.

…Click here to read more

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Treatment of rectal cancer can be improved by extra drug

Cancer cells may escape from chemotherapy but not from contraceptive drug

Better results have been found by adding cancer medicine Avastin to radiation and chemotherapy among the patients with rectal cancer.

And adding the contraceptive drug mifepristone (RU-486) to chemotherapy destroys ovarian cancer cells that remained after cisplatin cure. These are the results of two reports presented Tuesday at the American Association for Cancer Research annual meeting, in San Diego.
According to first study adding Avastin to chemotherapy and radiation enhanced three-year, disease-free existence by 91 percent in patients with rectal cancer
…Click here to read more

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Inherited Connection to Lungs Cancer

Nicotine Addiction in the Perils of Fatalism

An inherited alternative has been enormously acknowledged just in recent times. It leads the chain smoking people extra elastic towards their trend of addiction along with nicotine’s. The use of much expandable smoking raised a lot of risk factors among the people as the scientists and the laboratory physician of Pathology in a minute ago diagnosed. The continuous use of smoking will lead the smokers at marginal level of the lungs cancer. This crucial research is done by the National Institute on Drug Abuse as well as given by the National Institute of Health.

The chief executive of NIH Dr. Elias Zerhouni demonstrated a most occurring prediction. The all researches and studies will soon press forward the chances of hereditary investigations. This will more classify all the DNA discrepancies. Which will in future enhance the threat of complicated bio deeds muddles?

…Click here to read more

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ACORN Focusing On Underserved Communities for Cancer-Related Clinical Trials

“Accelerated Community Oncology Research Network Inc. (ACORN)” is a unique network consisting of progressive community clinics working together to change how the pattern of the clinical trials could be better implemented. It was founded primarily as ‘The West Clinic’ in Memphis, Tennessee to address the inefficiencies of clinical research. It consists of a group of experts dealing with clinical research, oncology, data management, regulatory, information technology, business development etc.

 It has recently come with an announcement that it is going to include underserved communities like African Americans in. The number has increased to 32% from 20% since 2007.

 Lee S. Schwartzberg, MD, President of ACORN says that    “Community oncology clinics care for over 84% of the nation’s cancer patients”. These clinics have dramatically improved access to care including the underserved.

  According to the 2000 census, African Americans make up 12.9% of the US population; however they represent only 7.46% of all clinical trial participants down from 7.9%. The reason behind less participation of this sect of population is lack of awareness among them of the availability of such trials.

 NCI has also noticed that the physicians don’t discuss the availability of such facilities with these minority groups and there is lack of enough set ups providing such clinical trials to the patients.

 There has also been found a problem with the way these clinical trials have been designed. They are too meticulous and standardized and may not include many patients suffering from multiple problems which are more prevalent among the people belonging to the minority population. 

 Steve Coplon, CEO, has however shown determination to overcome these overcomes these hurdles by crafting a new user friendly model more relevant for these minority groups.  

 ACORN already provides patients to take advantage of hundred of leading- edge clinical trials for all major cancer disease types in other communities. They are now working upon increasing the participation of the minority in these clinical research operations.

 For promoting the participation, they have been spreading awareness the minority and they are trying to spread information about the research possibilities. They are being convinced that participating in the study would provide them with an opportunity to get monitored and receive the highest standard of health care.

 Dr. Schwartzberg stated,”Using Community Oncology as the vehicle, we are advancing the War on Cancer to all patient populations”. He says that it is in a manner consistent with the goals laid out in the “President’s Annual Report on Cancer.”

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Paternal Exposure to Toxins Affects Fetal and Post Natal Development of Offspring

Scientists have been conducting researches for a long time and now they have come up with sound evidences that the paternal exposure could be making serious impacts on the fetal and post-natal development of the offspring. It is more likely that such imprints will also be reflected in subsequent future generations as well.Until now the maternal exposure to several of the dangerous toxic agents during the period of pregnancy were the prime concerns for experts, scientists, and society at large.

The American Association for the Advancement of Science’ sponsored a multidisciplinary symposium recently. This symposium was focused on the concept of “Father and Fetus”. Scientists in this symposium presented many evidences that the reproductive success and post-natal development processes could be severely affected by the male-mediated influences and this may continue from one generation to another.

Evidences supported by the results obtained from certain specific animal and epidemiological studies demonstrate that paternal exposure to the various types of potentially harmful and hazardous toxins can severely affect the development process of fetus. Such negative impacts could also bring selected but wide spectrum defects and deficits in the offspring’s and there is a strong possibility that such impacts would also be reflected in the future generations as well.

Dr. Gladys Friedler, an emeritus Professor of Psychology at the Boston University School of Medicine highlighted the issue with much concern for all. Organizing a session in the symposium, he specified an urgent need of increasing the awareness levels of everyone about the “significant effect of the male parent in reproductive success and postnatal developments as well as to stimulate research on male-mediated effects”, he says.

Dr. Gladys Friedler, a pioneer researcher, presented a complete review of the researches and studies conducted in this regard and highlighted that all of them indicate clearly that the exposure to the toxins in the form of both the recreational and therapeutic drugs is equally dangerous for a male. Similarly, the exposures at the workplaces and other types of exposure are equally risky in case males as all this could potentially affect and alter the reproductive outcomes.

There are certain impacts on the offspring outcome that have been very specifically reported. Such instances include problems like low birth weight. Growth in childhood cancer cases, Problems related to overall development, behavioral disorders, typical endocrine abnormalities, and some specific cross- generational impacts. Dr. Gladys Friedler is quite hopeful that further research would help in solving these puzzled and complex issues that are directly related to the future generations.